{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:25:11Z","timestamp":1781231111485,"version":"3.54.1"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[1998,2,1]],"date-time":"1998-02-01T00:00:00Z","timestamp":886291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Wild-type Daniel\u2019s strain of Theiler\u2019s virus (wt-DA) induces a chronic demyelination in susceptible mice which is similar to multiple sclerosis. A variant of wt-DA (designated DA-P12) generated during the 12th passage of persistent infection of a G26-20 glioma cell line failed to persist and induce demyelination in SJL\/J mice. To identify the determinants responsible for this change in phenotype, we sequenced the capsid coding sequence (nucleotides [nt] 2991 to 3994) and found three mutations in VP1: residues 99 (Gly to Ser), 100 (Gly to Asp), and 103 (Asn to Lys). To study the role of these mutations in neurovirulence and demyelination, we prepared a recombinant virus, DAP-1C-2A\/DA, with replacement of wt-DA nt 2991 to 3994 with the corresponding region of DA-P12, and viruses with individual point mutations at VP1 residues 99(Ser), 100(Asp), and 103(Lys). DAP-1C-2A\/DA and viruses with a mutation at VP1 residue 99 or 100 (but not 103) completely attenuated the ability of wt-DA to induce demyelination. Failure to induce demyelination was not due to a general failure in growth, since DA-P12 and other mutant viruses lysed L-2 cells in vitro as effectively as wt-DA. The change in disease phenotype was independent of the specific B- or T-cell immune recognition because a decrease in the neurovirulence of mutant viruses was observed in neonatal mice and immune-deficient RAG1 \u2212\/\u2212 mice. This difference in neurovirulence is not the complete explanation for the failure of DA-P12 to demyelinate, since virus with a mutation at residue 103(Lys) had decreased neurovirulence but did induce demyelination. Therefore, point mutation at VP1 residue 99 or 100 altered the ability of wt-DA to demyelinate, perhaps related to a disruption in interaction between virus and receptor on certain neural cells.<\/jats:p>","DOI":"10.1128\/jvi.72.2.1262-1269.1998","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T18:07:22Z","timestamp":1577815642000},"page":"1262-1269","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["Molecular Characterization of a Nondemyelinating Variant of Daniel\u2019s Strain of Theiler\u2019s Virus Isolated from a Persistently Infected Glioma Cell Line"],"prefix":"10.1128","volume":"72","author":[{"given":"Xiaoqi","family":"Lin","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Departments of Immunology1 and"},{"name":"<!--label omitted: 2-->Neurology,2 Mayo Clinic, Rochester, Minnesota 55905, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Sato","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Neurology, University of Chicago Medical Center, Chicago, Illinois 606373"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Patick","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Neurology,2 Mayo Clinic, Rochester, Minnesota 55905, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry R.","family":"Pease","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Immunology1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond P.","family":"Roos","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Neurology, University of Chicago Medical Center, Chicago, Illinois 606373"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Departments of Immunology1 and"},{"name":"<!--label omitted: 2-->Neurology,2 Mayo Clinic, Rochester, Minnesota 55905, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(87)90021-2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.4049\/jimmunol.135.2.1408","article-title":"Theiler\u2019s murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity","volume":"135","author":"Clatch R. J.","year":"1985","unstructured":"Clatch R. J. Melvold R. W. Miller S. D. Lipton H. L. Theiler\u2019s murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity.J. Immunol. 135 1985 1408 1414","journal-title":"J. Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.8.4823-4829.1995"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.12.8386-8391.1994"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.96.6.517"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.490150406"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.0067"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.11.8213-8217.1996"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(76)90167-2"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270424"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.9951"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.11.5.1147-1155.1975"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.40.2.560-567.1981"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.6.2409"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90030-G"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(88)90642-3"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-9-2123"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1179\/his.1989.12.1.35"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)65563-3"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.7.964"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.163.3.620"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130409"},{"key":"e_1_3_2_24_2","first-page":"672","article-title":"Neonatal infection with the Daniel\u2019s strain of Theiler\u2019s murine encephalomyelitis virus","volume":"49","author":"Rodriguez M.","year":"1983","unstructured":"Rodriguez M. Leibowitz J. L. Powell H. C. Lampert P. W. Neonatal infection with the Daniel\u2019s strain of Theiler\u2019s murine encephalomyelitis virus.Lab. Invest. 49 1983 672 679","journal-title":"Lab. Invest."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(86)90062-7"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(82)90057-1"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.12.5492-5496.1989"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.10.4469-4473.1989"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0660"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.80.2066.122.b"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.2.1219-1223.1994"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.4.1929-1937.1991"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.2.1023-1030.1991"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.72.2.1262-1269.1998","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.72.2.1262-1269.1998","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T15:04:06Z","timestamp":1695567846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.72.2.1262-1269.1998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1128\/JVI.72.2.1262-1269.1998"],"URL":"https:\/\/doi.org\/10.1128\/jvi.72.2.1262-1269.1998","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]},"assertion":[{"value":"1997-06-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-10-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}